Barbara Duncan has served as a Non-Executive Director since June 2016. She has over 15 years of experience in the life sciences industry and has served as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) since May 2009 and as Chief Financial Officer and then Chief Executive Officer at DOV Pharmaceuticals, Inc. from 2001 to 2009.
Biotechnology, Biochemistry